AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2017

May 25, 2017

32939_dirs_2017-05-25_06f27bf0-69d3-461d-b519-0645d3cac590.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2017-05-23

Reporting Person: Campbell Chad Thomas (SVP/GM, Vascular Access)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-23	Common Stock	F	788	$15.82	Disposed	12264	Direct

Footnotes

F1: The exempt disposition of 788 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016.